Circle
Circle
Circle
Cube
CircleCircle
Circle
CircleCircle
Shapes

News & Views

At Enveda, we are tackling the toughest challenges in drug discovery, finding and developing new compounds from the expanse of the natural world. We’re doing it with metabolomics and machine learning that allow us to characterize those compounds in entirely new ways. All of us at Enveda share a commitment to the health of those who will use the drugs we’re developing today.

Subscribe to follow our progress.

Subscribe

Highlights

12/21/2022

'As the market has turned': Enveda secures $68M to move revised pipeline into the clinic in 2023

Enveda will enter the clinic next year with at least one of three main programs

Read more

12/21/2022

Enveda closes $68-million combined Series B equity and debt financing

Round included multiple new institutional investors and all its current major investors

Read more

11/11/2022

TRANSFORMing natural product drug discovery: machine learning for high-fidelity chemical property prediction from metabolomics data

The core problem in natural product drug discovery: finding needles in nature’s haystack.

Read more

10/19/2022

Natural Products in Protein Degradation: Past, Present, and Future

Protein degradation, whether as a PROTAC (proteolysis targeting chimera) or a molecular glue, is an emerging new modality of therapeutic action...

Read more

06/22/2021

Lux Capital Leads $51 Million Financing in Biotech Startup Enveda - Company searches for compounds from nature to develop medications

Lux Capital has led a $51 million venture-capital financing in Enveda Biosciences Inc., a biotechnology startup led by an entrepreneur who previously helped...

Read more

News

'As the market has turned': Enveda secures $68M to move revised pipeline into the clinic in 2023

Enveda will enter the clinic next year with at least one of three main programs

Read more

Enveda closes $68-million combined Series B equity and debt financing

Round included multiple new institutional investors and all its current major investors

Read more

TRANSFORMing natural product drug discovery: machine learning for high-fidelity chemical property prediction from metabolomics data

The core problem in natural product drug discovery: finding needles in nature’s haystack.

Read more

Natural Products in Protein Degradation: Past, Present, and Future

Protein degradation, whether as a PROTAC (proteolysis targeting chimera) or a molecular glue, is an emerging new modality of therapeutic action...

Read more

Enveda Biosciences to Open Advanced Drug Discovery and Development Center in Boulder, Colo.; Lead Optimization Laboratory in Hyderabad, Telangana, India

Enveda Biosciences to Open Advanced Drug Discovery and Development Center in Boulder, Colo.; Lead Optimization Laboratory in Hyderabad, Telangana, India...

Read more

Enveda Biosciences Adds Drug Development Leaders to Scale Efforts and Accelerate Progress

New team members deepen Enveda’s global drug development expertise as its therapeutics pipeline expands and advances...

Read more

A Recursion veteran is mapping plant life to chart a course to new therapies — and investors like what they see

One of the earliest employees at AI biotech Recursion Pharmaceuticals is leading a new company, and he’s just closed a hefty Series A to get things moving...

Read more

Lux Capital Leads $51 Million Financing in Biotech Startup Enveda - Company searches for compounds from nature to develop medications

Lux Capital has led a $51 million venture-capital financing in Enveda Biosciences Inc., a biotechnology startup led by an entrepreneur who previously helped...

Read more

Enveda Biosciences Closes $51M Series A Financing Led by Lux Capital

Enveda Biosciences, a leading biotechnology company harnessing the power of nature’s chemistry to develop next-gen small molecule therapeutics, today announc...

Read more

Exploiting the Therapeutic Potential of Plants

Technology Networks recently interviewed Viswa Colluru, founder and CEO of Enveda Biosciences, to find out how the company is “harnessing the complexity of...

Read more

Exclusive: Enveda Biosciences Announces $4.9M Seed To Create Medicinal Plant Database

Enveda Bioscienes has raised a seed round of $4.9 million to build what it touts to be the “world’s largest database of anthropological, chemical and biologi...

Read more

Enveda Biosciences Systematically Harnesses Untapped Potential of Nature’s Chemistry to Develop Next-Gen Therapeutics

Enveda Biosciences today announced its seed round of funding in the amount of $4.9 million led by True Ventures, with participation from Wireframe Ventures...

Read more

Why we invested in Enveda

In the Spring of 2018, one of our LPs based in Salt Lake City introduced me to a founder named Dan Wee from the vibrant bioscience community there...

Read more

Bioactivity-Based Molecular Networking for the Discovery of Drug Leads in Natural Product Bioassay-Guided Fractionation

It is a common problem in natural product therapeutic lead discovery programs that despite good bioassay results in the initial extract, the active compound...

Read more

Mass spectrometry searches using MASST

Introduced in 1990, a tool for discovering related protein or gene sequences named Basic Local Alignment Search Tool (BLAST) enabled researchers to query...

Read more

Global chemical effects of the microbiome include new bile-acid conjugations

A mosaic of cross-phylum chemical interactions occurs between all metazoans and their microbiomes...

Read more

Celebrating the departure of an outstanding employee

A few weeks ago, Viswa Colluru, a Senior Product Manager at Recursion, scheduled time with me to share that he would be leaving Recursion...

Read more
Arrow leftArrow right

Thought Leadership

Machine Learning will Revolutionize Metabolomics

Metabolomics is a rapidly emerging field that seeks to measure the landscape of metabolites, or organic small molecules, in liv...

Read more

Fulfilling the Promise of Natural Products with Technology: Discovering the Next Generation of Small Molecules

In twenty years of Big Pharma experience, I have seen both the promise of small-molecule Drug Discovery (helping take four mole...

Read more

Drug Discovery Productivity at Enveda —Biotech Innovation with Big Pharma Efficiency

Once the initial project goals are defined, biologists build assays that can reproducibly evaluate compounds (agonists, antagon...

Read more

Artemisinins, Malaria, and The Quest to Systematize Collaboration between Nature and Scientists (Cures and Nobel Prizes)

Mother Nature is, by far, the most accomplished drug discovery researcher in the history of the world, in spite of the fact..

Read more
Arrow leftArrow right

Subscribe To Follow Our Progress.

Subscribed successfully!
Oops! Something went wrong while submitting the form.